Valencia Nutrition Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003370,
    "name": "Valencia Nutrit.",
    "stock_name": "Valencia Nutrit.",
    "full_name": "Valencia Nutrition Ltd",
    "name_url": "stocks-analysis/valencia-nutrit",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "73.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "73.00",
    "mcapval": "122.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 542910,
    "symbol": "",
    "ind_name": "FMCG",
    "ind_code": 70,
    "indexname": "",
    "isin": "INE08RT01016",
    "curr_date": "Dec 03",
    "curr_time": "",
    "bse_nse_vol": 3000,
    "exc_status": "Active",
    "traded_date": "Dec 03, 2025",
    "traded_date_str": "2025 12 03",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/valencia-nutrit-1003370-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Valencia Nutrit. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-valencia-nutrit-overvalued-or-undervalued-3713675",
        "imagepath": "",
        "date": "2025-11-19 08:10:49",
        "description": "As of 18 November 2025, the valuation grade for Valencia Nutrit. has moved from does not qualify to very expensive, indicating a significant shift in its perceived market value. The company is currently overvalued based on its financial metrics, which include a PE ratio of 119.26, an EV to EBIT of 134.93, and an EV to Sales ratio of 15.93. These ratios suggest that the stock is trading at a premium compared to its earnings and sales, raising concerns about its sustainability.\n\nIn comparison to its peers, Valencia Nutrit. stands out with a notably high PE ratio of -57.79, while Page Industries has a PE of 57.65 and Jubilant Food at 123.74, both indicating a stark contrast in valuation. The company's return on capital employed (ROCE) is a mere 1.30%, and its return on equity (ROE) is at 2.98%, which are significantly lower than the industry averages. Recent performance shows that while the stock has outperfor..."
      },
      {
        "title": "Is Valencia Nutrit. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-valencia-nutrit-overvalued-or-undervalued-3710004",
        "imagepath": "",
        "date": "2025-11-18 08:26:41",
        "description": "As of 17 November 2025, the valuation grade for Valencia Nutrit. has moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. The company is currently overvalued, with a PE ratio of 119.26, an EV to EBITDA ratio of 134.93, and a ROE of only 2.98%. These ratios suggest that the stock is trading at a premium compared to its earnings and cash flow generation capabilities.\n\nIn comparison to its peers, Valencia Nutrit. stands out unfavorably; for instance, Page Industries has a PE ratio of 57.64, while Jubilant Food's PE ratio is 124.47, both indicating more reasonable valuations relative to their performance. The recent stock performance shows a stark contrast to the Sensex, with Valencia Nutrit. experiencing a 1-week return of -22.61% against the Sensex's 1.69%, reinforcing the notion that the stock is currently overvalued...."
      },
      {
        "title": "How has been the historical performance of Valencia Nutrit.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-valencia-nutrit-3699589",
        "imagepath": "",
        "date": "2025-11-13 23:42:54",
        "description": "Answer:\nThe historical performance of Valencia Nutrit shows significant fluctuations in its financial metrics over the years, culminating in a notable improvement in the latest fiscal year.\n\nBreakdown:\nValencia Nutrit's net sales have increased dramatically from 1.34 Cr in Mar'24 to 8.47 Cr in Mar'25, following a gradual rise from 1.46 Cr in Mar'23 and 0.95 Cr in Mar'21. The total operating income also reflects this upward trend, reaching 8.47 Cr in Mar'25 compared to 1.34 Cr in Mar'24. However, the raw material costs surged to 5.81 Cr in Mar'25 from 1.44 Cr in Mar'24, impacting the overall expenditure, which rose to 7.70 Cr in Mar'25. Despite these costs, the operating profit (PBDIT) turned positive at 1.42 Cr in Mar'25, a significant recovery from the losses recorded in previous years. The profit before tax also improved to 1.07 Cr in Mar'25, while profit after tax mirrored this positive trend at 1.07 Cr...."
      }
    ],
    "total": 12,
    "sid": "1003370",
    "stock_news_url": "https://www.marketsmojo.com/news/valencia-nutrition-1003370"
  },
  "announcements": [
    {
      "caption": "Submission Of Disclosure Under Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015",
      "datetime": "01-Dec-2025",
      "details": "the Company has received the disclosure under Regulation 7(2)(b) of the SEBI (Prohibition of Insider Trading) Regulations 2015 with respect to the acquisition of shares by the Promoter/ Promoter group on November 27 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday November 25 2025",
      "datetime": "25-Nov-2025",
      "details": "The Board of Directors of the Company in its meeting today i.e. November 25 2025 approved the allotment of 250000 equity shares having a face value of Rs. 10/- each at a price of Rs 54 per equity share aggregating to Rs. 13500000 on Preferential basis by way of Private Placement.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Regarding Receipt Of In-Principle Approval Of BSE Limited For Issue Of Equity Shares To Promotor And Non-Promotor Category On A Preferential Basis.",
      "datetime": "15-Nov-2025",
      "details": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 the company has received In-Principle approval for issue of equity shares on a preferential basis dated November 14 2025 from BSE Limited to be issued to promotor and non-promotor category for consideration on a preferential basis.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Valencia Nutrit. overvalued or undervalued?

2025-11-19 08:10:49

As of 18 November 2025, the valuation grade for Valencia Nutrit. has moved from does not qualify to very expensive, indicating a significant shift in its perceived market value. The company is currently overvalued based on its financial metrics, which include a PE ratio of 119.26, an EV to EBIT of 134.93, and an EV to Sales ratio of 15.93. These ratios suggest that the stock is trading at a premium compared to its earnings and sales, raising concerns about its sustainability. In comparison to its peers, Valencia Nutrit. stands out with a notably high PE ratio of -57.79, while Page Industries has a PE of 57.65 and Jubilant Food at 123.74, both indicating a stark contrast in valuation. The company's return on capital employed (ROCE) is a mere 1.30%, and its return on equity (ROE) is at 2.98%, which are significantly lower than the industry averages. Recent performance shows that while the stock has outperfor...

Is Valencia Nutrit. overvalued or undervalued?

2025-11-18 08:26:41

As of 17 November 2025, the valuation grade for Valencia Nutrit. has moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. The company is currently overvalued, with a PE ratio of 119.26, an EV to EBITDA ratio of 134.93, and a ROE of only 2.98%. These ratios suggest that the stock is trading at a premium compared to its earnings and cash flow generation capabilities. In comparison to its peers, Valencia Nutrit. stands out unfavorably; for instance, Page Industries has a PE ratio of 57.64, while Jubilant Food's PE ratio is 124.47, both indicating more reasonable valuations relative to their performance. The recent stock performance shows a stark contrast to the Sensex, with Valencia Nutrit. experiencing a 1-week return of -22.61% against the Sensex's 1.69%, reinforcing the notion that the stock is currently overvalued....

How has been the historical performance of Valencia Nutrit.?

2025-11-13 23:42:54

Answer: The historical performance of Valencia Nutrit shows significant fluctuations in its financial metrics over the years, culminating in a notable improvement in the latest fiscal year. Breakdown: Valencia Nutrit's net sales have increased dramatically from 1.34 Cr in Mar'24 to 8.47 Cr in Mar'25, following a gradual rise from 1.46 Cr in Mar'23 and 0.95 Cr in Mar'21. The total operating income also reflects this upward trend, reaching 8.47 Cr in Mar'25 compared to 1.34 Cr in Mar'24. However, the raw material costs surged to 5.81 Cr in Mar'25 from 1.44 Cr in Mar'24, impacting the overall expenditure, which rose to 7.70 Cr in Mar'25. Despite these costs, the operating profit (PBDIT) turned positive at 1.42 Cr in Mar'25, a significant recovery from the losses recorded in previous years. The profit before tax also improved to 1.07 Cr in Mar'25, while profit after tax mirrored this positive trend at 1.07 Cr....

View All News